Double-blind trial of anorectic agents.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000661:Amphetamine / Q000009:adverse effects / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use*; D004038:Diet, Reducing; D004342:Drug Hypersensitivity; D004357:Drug Synergism; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D008702:Methaqualone / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D010146:Pain / Q000209:etiology; D010627:Phenethylamines / Q000627:therapeutic use*; D010645:Phentermine / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D019966:Substance-Related Disorders; D013997:Time Factors
D001067:Appetite Depressants; D010627:Phenethylamines; D010919:Placebos; D008702:Methaqualone; D010645:Phentermine; D000661:Amphetamine; D003913:Dextroamphetamine